MARKET

LEXXW

Lexaria Bioscien
LEXXW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0018
0.0332
0.0078
-
Lexaria completes dosing in animal study testing oral DehydraTECH formulations for retatrutide, amycretin
PUBT · 23h ago
Lexaria Bioscience to attend BIO International Convention
PUBT · 6d ago
Lexaria wins ethics board clearance for oral semaglutide human pilot study #7
PUBT · 05/19 13:15
Lexaria CEO says pharma partner extends material transfer agreement through end-2026
PUBT · 05/07 13:25
Lexaria seeks ethics approval for five-week oral semaglutide study versus Wegovy tablets
PUBT · 05/05 13:10
Lexaria CEO discusses DehydraTECH, GLP-1 strategy in new investor video series interview
PUBT · 05/01 13:27
Lexaria extends PharmaCO transfer agreement through Dec. 31, 2026
PUBT · 04/29 13:17
Lexaria signs CRO contracts for GLP-1 animal study #2
PUBT · 04/23 13:09
More

Webull offers Lexaria Bioscien stock information, including NASDAQ: LEXXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXXW stock methods without spending real money on the virtual paper trading platform.